Group 1 - The company, established in 2010, is listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board as of May 9, 2024 [2] - It is recognized as a key enterprise in the national "specialized, refined, distinctive, and innovative" category, a national high-tech enterprise, and a national intellectual property advantage enterprise [2] - The company has five production bases located in Shaoguan, Dongguan, Shaoguan Luyuan, Hefei, and Shaoguan Mingyue Lake (under construction) [2] Group 2 - The main business segments include high-performance target materials, high-performance metals, and key materials and core components in cutting-edge technology fields [2] - The company plans to increase investment in technology research and development while expanding the production scale of high-performance sputtering targets [2] - The goal is to become a well-known manufacturer with significant market competitiveness and industry influence [2]

Core Viewpoint - The company has recently obtained a patent for an invention related to a reaction cup guiding and self-lubricating mechanism, which enhances the accuracy of blood coagulation analysis [1] Group 1: Patent Details - The patent is titled "Reaction Cup Guiding and Self-Lubricating Mechanism for Coagulation Analyzers" with patent number ZL202510542311.9 [1] - The invention includes components such as a base, annular pressing block, and clamping elastic body, aimed at improving the positioning accuracy of the reaction cup [1] Group 2: Impact on the Company - The patent is not expected to have a significant immediate impact on the company's production and operations [1] - However, it is beneficial for leveraging the company's intellectual property advantages, promoting technological innovation, and enhancing core competitiveness [1] - The invention contributes to establishing a continuous innovation mechanism within the company [1]

| 证券代码：300406 | 证券简称：九强生物 | 公告编号：2025-008 | | --- | --- | --- | | 债券代码：123150 | 债券简称：九强转债 | | 北京九强生物技术股份有限公司 关于公司获得发明专利证书的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 注：发明专利权期限为自申请日起二十年。 发明专利摘要： 北京九强生物技术股份有限公司（以下简称"九强生物"或"公司"）于近 期收到日本专利局颁发的 1 项专利证书，具体情况如下： | 一、专利基本情况 | | --- | | 序号 | 专利号 | 专利名称 | 专利权人 专利类型 | 申请日期 | 授权日期 | 证书号 | | --- | --- | --- | --- | --- | --- | --- | | | | 6-磷酸葡萄 | | | | | | | | 糖脱氢酶突 | | | | | | 1 | 7634544 | 变体及其在 | 九强生物 发明 | 2020.11.04 | 2025.02.13 | N/A | | | | 制备检测试 | | | | | ...